An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

An accurate estimate of patient survival at diagnosis is critical to plan efficient therapeutic options. A simple and multiapplication tool is needed to move forward the precision medicine era. Taking advantage of the broad and high CD10 expression in stem and cancers cells, we evaluated the molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Guyot, Boris, Clément, Flora, Drouet, Youenn, Schmidt, Xenia, Lefort, Sylvain, Delay, Emmanuel, Treilleux, Isabelle, Foy, Jean-Philippe, Jeanpierre, Sandrine, Thomas, Emilie, Kielbassa, Janice, Tonon, Laurie, Zhu, Helen He, Saintigny, Pierre, Gao, Wei-Qiang, de la Fouchardiere, Arnaud, Tirode, Franck, Viari, Alain, Blay, Jean-Yves, Maguer-Satta, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540743/
https://www.ncbi.nlm.nih.gov/pubmed/37707389
http://dx.doi.org/10.1158/2767-9764.CRC-23-0196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540743/
https://www.ncbi.nlm.nih.gov/pubmed/37707389
http://dx.doi.org/10.1158/2767-9764.CRC-23-0196

Ejemplares similares